A genetic test can estimate your risk of male pattern baldness, but it cannot accurately predict whether you will develop it, when hair loss may begin, or how severe it will be.
What a genetic test can tell you about baldness risk
The test cannot predict exactly how your hairline will change. It compares common DNA variants linked to male pattern baldness with patterns seen in earlier population data, then places you in a higher, lower, or middle risk group.
Many genetic variants contribute small amounts to your overall risk. No single gene decides the outcome. Your age, family history, and current scalp health tell you much more than a DNA score alone.
A genetic risk score estimates risk based on population data but cannot predict when you will lose hair. A higher-risk score says your DNA pattern resembles that of men who more often develop noticeable hair loss. A lower-risk score still does not rule out gradual thinning.
What the test’s numbers can and cannot show
To measure how well a genetic test predicts hair loss, researchers use an accuracy score called the AUC (area under the curve). An AUC of 0.5 means the model does no better than a coin flip, and 1.0 means it separates the groups perfectly.
Most hair-loss models fall in between, and the useful question is which groups they were built to separate.
Genetic tests are better at identifying severe hair loss
A large 2017 analysis of men in the UK Biobank built a model on about 40,000 men and tested it on another 12,000 men. When it compared men with no hair loss with men who had severe hair loss, the AUC was 0.78.1
In that study’s comparison, 59% of the men the model labeled high risk actually had severe hair loss, a figure that does not carry over to commercial kits. The rest did not.
Genetic tests are less accurate at predicting mild or moderate hair loss
A 2023 model based on large European datasets showed why the amount of hair loss matters. Mild hair loss had an AUC around 0.60, and moderate hair loss around 0.63.2 The models were much less accurate at distinguishing mild or moderate hair loss than severe hair loss.
| What the model compared | AUC range | How to read it |
|---|---|---|
| Severe hair loss (two large models) | 0.73-0.78 | Useful separation in a group, but still not a personal forecast |
| Moderate hair loss | about 0.63 | Close to guessing |
| Mild hair loss | about 0.60 | Close to guessing |
| European-built model used in African men | 0.51-0.55 | About the same as chance |
A high-risk result is still not a diagnosis
A 2015 model tested in European men shows how a high-risk label can mislead in younger men. Among men under 50, sensitivity was 87.1%, but specificity was 42.4%.3 Sensitivity means the model caught most men who would develop early thinning. Specificity measures how often it correctly identified men who would not.
Low specificity means the model predicted that many younger men would thin even though they would not. That model came from forensic research on estimating appearance from DNA, not from a clinic exam.
Why genetic test accuracy varies by ancestry
A risk model is only as useful as the population it was built on. Researchers developed most hair-loss risk scores mainly in European populations, so that the same number may not fit other people too well
A 2025 study of 2,136 men from Ghana, Nigeria, Senegal, and South Africa tested a European-built score. It predicted hair loss with an AUC of 0.51 to 0.55, about the same as chance.4
That does not mean those men had no hair loss. It means the score often did not measure their actual risk well. Asian data are also limited. In a small 2024 study of Han Chinese men, only 1 of 25 variants drawn from European studies showed a clear association after statistical correction.5
Should you trust a baldness gene test you order online?
You can order these tests without seeing a doctor, but interpreting the results can be difficult. They screen for common variants; they are not a medical diagnosis.
Clinicians caution that direct-to-consumer hair loss tests have strict limits and require careful interpretation. Consumer-directed tests also raise questions about accuracy, data security, and privacy because companies collect your DNA outside a medical visit.
Interpreting raw data through unaffiliated websites can add another layer of error. Published reports include cases in which a third-party tool flagged a genetic variant that later testing showed was not actually present in the sample.
Studies have examined whether a person’s DNA pattern predicts treatment response. A 2026 review found that no genetic marker is ready for daily use in choosing a hair-loss treatment.
Before you order a kit, check the company’s answers to four questions.
- Which hair-loss pattern does the test predict, and how is it defined?
- Which population was the risk model built and tested in?
- Will I receive raw genotype data, and who controls my sample?
- Does a doctor review the result, or does it only label a risk group?
Some men would rather skip the kit and start with a doctor’s visit. That path avoids questions about raw data storage and lets the doctor assess the actual pattern first.
Three clues that matter more than a genetic risk score
Before you spend time on a kit, three clinical factors can tell you more about your current hair loss.
- Your current scalp pattern and hair shaft thickness
- Your age and the speed of change you have noticed
- Your family history of noticeable hair loss on either side
A scalp exam shows whether the change follows the usual pattern of male pattern baldness or points to another cause such as iron deficiency, thyroid disease, or temporary shedding (like telogen effluvium). Those conditions can look similar but need different next steps.
Family history provides useful context but cannot predict when hair loss will begin. Age matters because the same gene pattern may look different at 28 than at 48.
If you are still deciding whether to test or what to do with a result, our doctors in Tokyo and Yokohama will review your scalp, hair pattern, and family history with you.
Frequently asked questions
- Can a genetic test tell me exactly when I will go bald?
-
No. It can place your risk in a broad category, but it cannot tell you the exact age, pattern, or final extent of hair loss.
- Is a high-risk baldness gene result a diagnosis?
-
No. A high-risk result means your genetic pattern is more common among men with a certain hair-loss pattern than among men without it. It doesn’t tell you whether you are currently losing hair or need treatment.
Bring the result and a short family history to a dermatologist. The doctor can compare the report with what is happening on your scalp.
- Should I take a baldness gene test before seeing a doctor about hair loss?
-
Not as a first step for most men. A scalp exam and history can often give clearer immediate clues about the current pattern and any reversible cause. If you already took one, treat the report as one piece of information, not a treatment plan.
References
1. Hagenaars, S. P., Hill, W. D., Harris, S. E., Ritchie, S. J., Davies, G., Liewald, D. C., Gale, C. R., Porteous, D. J., Deary, I. J., & Marioni, R. E. (2017). Genetic prediction of male pattern baldness. PLoS Genetics, 13(2), e1006594. https://doi.org/10.1371/journal.pgen.1006594
2. Chen, Y., Hysi, P., Maj, C., Heilmann-Heimbach, S., Spector, T. D., Liu, F., & Kayser, M. (2023). Genetic prediction of male pattern baldness based on large independent datasets. European Journal of Human Genetics, 31(3), 321-328. https://doi.org/10.1038/s41431-022-01201-y
3. Marcińska, M., Pośpiech, E., Abidi, S., Andersen, J. D., van den Berge, M., Carracedo, Á., Eduardoff, M., Marczakiewicz-Lustig, A., Morling, N., Sijen, T., Skowron, M., Söchtig, J., Syndercombe-Court, D., Weiler, N., EUROFORGEN-NoE Consortium, Schneider, P. M., Ballard, D., Børsting, C., Parson, W., … Branicki, W. (2015). Evaluation of DNA variants associated with androgenetic alopecia and their potential to predict male pattern baldness. PLoS One, 10(5), e0127852. https://doi.org/10.1371/journal.pone.0127852
4. Janivara, R., Hazra, U., Pfennig, A., Harlemon, M., Kim, M. S., Eaaswarkhanth, M., Chen, W. C., Ogunbiyi, A., Kachambwa, P., Petersen, L. N., Jalloh, M., Mensah, J. E., Adjei, A. A., Adusei, B., Joffe, M., Gueye, S. M., Aisuodionoe-Shadrach, O. I., Fernandez, P. W., Rohan, T. E., … Lachance, J. (2025). Uncovering the genetic architecture and evolutionary roots of androgenetic alopecia in African men. HGG Advances, 6(3), 100428. https://doi.org/10.1016/j.xhgg.2025.100428
5. Li, Y., Huang, H., Liang, B., Xiao, F. L., Zhou, F. S., Zheng, X. D., Yang, S., & Zhang, X. J. (2024). Association study reveals a susceptibility locus with male pattern baldness in the Han Chinese population. Frontiers in Genetics, 15, 1438375. https://doi.org/10.3389/fgene.2024.1438375
Yip, L., Rufaut, N., & Sinclair, R. (2011). Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know. The Australasian Journal of Dermatology, 52(2), 81-8. https://doi.org/10.1111/j.1440-0960.2011.00745.x
Gupta, A. K., Dennis, D. J., Economopoulos, V., & Piguet, V. (2026). The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives. Biology, 15(2). https://doi.org/10.3390/biology15020192
Horton, R., Crawford, G., Freeman, L., Fenwick, A., & Lucassen, A. (2019). Direct-to-consumer genetic testing with third party interpretation: beware of spurious results. Emerging Topics in Life Sciences, 3(6), 669-674. https://doi.org/10.1042/ETLS20190059





